Retrospective analysis of treatment patterns and outcomes with subcutaneous (SQ) bortezomib (BTZ) in patients (pts) with relapsed mantle cell lymphoma (MCL).
Vijayveer Bonthapally
Employment or Leadership Position - Millennium
Stock Ownership - Takeda
Marie-Helene Lafeuille
Research Funding - Millennium
Jonathan Fortier
Research Funding - Millennium
Mei Sheng Duh
Research Funding - Millennium
Yvette Ng
Employment or Leadership Position - Janssen
Stock Ownership - Johnson & Johnson
Helgi Van De Velde
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Liviu Niculescu
Employment or Leadership Position - Millennium
Esprit Ma
Employment or Leadership Position - Millennium
Andre Goy
No relevant relationships to disclose